[Mechanism inducing blood hypercoagulability in severe hypoxia].
D000313:Adrenal Medulla / Q000378:metabolism; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D001778:Blood Coagulation Disorders / Q000209:etiology* / Q000503:physiopathology; D001791:Blood Platelet Disorders / Q000209:etiology; D004837:Epinephrine / Q000378:metabolism / Q000494:pharmacology*; D000860:Hypoxia / Q000097:blood* / Q000150:complications; D007275:Injections, Intravenous; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D010646:Phentolamine / Q000494:pharmacology; D010714:Phosphatidylethanolamines / Q000097:blood; D013154:Spleen / Q000503:physiopathology; D013916:Thrombelastography; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D010714:Phosphatidylethanolamines; D010100:Oxygen; D004837:Epinephrine; D010646:Phentolamine
Mécanisme déclenchant l'hypercoagulabilité sanguine dans l'hypoxie sévère.